Andrew J. Bukowinski, M.D., M.S.

  • Assistant Professor of Pediatrics, UPMC Children's Hospital of Pittsburgh

Dr. Andrew Bukowinski joined the staff at UPMC Children's Hospital of Pittsburgh in 2015 after completing his Hematology Oncology Fellowship at Cincinnati Children's Hospital Medical Center.

Dr. Bukowinski's primary area of interest is in the development of new therapies to treat pediatric cancer and actively involved in clinical trials with the Children's Oncology Group Phase I consortium. His area of clinical expertise is relapsed and refractory tumors, Neuro-Oncology & Oncology.

Education & Training

  • 2015: Fellowship-Cincinnati Children's Hospital Medical Center, Cincinnati, OH
  • 2015: Masters of Science in Clinical and Translational Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
  • 2012: Residency - The UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
  • MD-University at Buffalo School of Medicine and Biomedical Science, New York, Buffalo, NY

Representative Publications

Research Interests

Developmental Therapeutics/COG. Dr. Andrew Bukowinski is an active coinvestigator for developmental therapies for the COG phase I program. UPMC Children’s Hospital of Pittsburgh is one of the few hospitals in the country conducting clinical research on novel therapies for children with cancer.

Pediatric Brain Tumor Consortium (PBTC). Dr. Andrew Bukowinski is an active co-investigator for developmental therapies for the PBTC. UPMC Children’s Hospital of Pittsburgh is one of the few hospitals in the country conducting clinical research on novel therapies for children with brain tumors.

Division